Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015–17

医学 阿奇霉素 肺炎链球菌 马车 抗药性 随机对照试验 抗菌剂 药品 微生物学 抗生素 免疫学 内科学 抗生素耐药性 泰利霉素 病毒学 链球菌科 红霉素
作者
John D Hart,Lyson Samikwa,Harry Meleke,Sarah E Burr,Jennifer Cornick,Khumbo Kalua,Robin L. Bailey
出处
期刊:The Lancet microbe [Elsevier BV]
卷期号:3 (2): e142-e150 被引量:26
标识
DOI:10.1016/s2666-5247(21)00279-2
摘要

Background Azithromycin mass drug administration (MDA) could reduce child mortality. However, macrolide resistance, which has generally been reported to develop after whole-community MDA for trachoma control, is a concern, and it has less commonly been studied in the context of treating children to reduce mortality. Here, we report on macrolide resistance after biannual azithromycin MDA at the Malawi site of the MORDOR study. Methods In the MORDOR cluster-randomised trial in Malawi, 30 communities in Mangochi District were randomly selected. Communities were randomly assigned to receive azithromycin or placebo by simple randomisation without stratification. Children aged 1–59 months were administered azithromycin 20 mg/kg or placebo as an oral suspension biannually for a total of four treatments in 2015–17. 1200 children (40 children per community) were randomly selected for nasopharyngeal swabs at baseline, 12 months (6 months after the second treatment visit), and 24 months (6 months after the fourth treatment visit). Samples were processed to culture Streptococcus pneumoniae . The primary outcome was the proportion of S pneumoniae isolates exhibiting macrolide resistance at 12 months and 24 months, assessed in the intention-to-treat population. The study is registered with ClinicalTrials.gov, NCT02048007. Findings At baseline, 3467 (76%) of 4541 eligible children in the azithromycin group and 3107 (72%) of 4308 eligible children in the placebo group were treated. 564 nasopharyngeal swabs were taken from the azithromycin group and 563 from the placebo group, with similar numbers of swabs taken at 12 months and 24 months. In both groups at baseline, carriage of S pneumoniae was greater than 85% and the proportion of strains resistant to macrolides was 28%. At the 12-month follow-up, macrolide resistance was higher in the azithromycin group (36·9%, 95% CI 32·5–41·2) than in the placebo group (21·6%, 17·7–25·4; OR 2·26, 95% CI 1·46–3·49; p=0·0002). At 24 months, macrolide resistance remained higher in the azithromycin group (43·9%, 39·2–48·5) compared with placebo (32·8%, 28·5–37·1; OR 1·66, 1·15–2·40; p=0·0069). Interpretation These findings support previous evidence from trachoma MDA programmes and suggest that monitoring of macrolide resistance should remain a key component of azithromycin interventions for reducing child mortality. Funding Bill & Melinda Gates Foundation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
尊嘟假嘟发布了新的文献求助10
刚刚
刚刚
尊嘟假嘟发布了新的文献求助10
刚刚
华仔的应助被年轻的抽屉采纳,获得10
刚刚
流云完成签到,获得积分10
2秒前
2秒前
3秒前
酷儿完成签到,获得积分10
3秒前
JiangJun发布了新的文献求助10
3秒前
天堂鸟完成签到,获得积分10
4秒前
尊嘟假嘟发布了新的文献求助10
4秒前
尊嘟假嘟发布了新的文献求助10
4秒前
王鹏发布了新的文献求助10
4秒前
充电宝的应助被rslysywd采纳,获得10
5秒前
6秒前
6秒前
权瑞松完成签到,获得积分20
6秒前
黄毛虎发布了新的文献求助10
6秒前
7秒前
落叶归根完成签到 ,获得积分10
7秒前
7秒前
1313完成签到,获得积分10
7秒前
尊嘟假嘟发布了新的文献求助10
7秒前
8秒前
尊嘟假嘟发布了新的文献求助10
8秒前
万事胜意发布了新的文献求助10
8秒前
尊嘟假嘟发布了新的文献求助10
8秒前
我是老大的应助被个性向卉采纳,获得10
9秒前
句式杂糅完成签到,获得积分10
9秒前
lx的应助被怪怪采纳,获得10
9秒前
lx的应助被怪怪采纳,获得10
9秒前
menyu发布了新的文献求助10
12秒前
12秒前
12秒前
尊嘟假嘟发布了新的文献求助10
12秒前
华仔的应助被xyry采纳,获得10
12秒前
HCH发布了新的文献求助10
13秒前
尊嘟假嘟发布了新的文献求助10
14秒前
qiuxu完成签到,获得积分10
16秒前
黄毛虎发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186898
求助须知:如何正确求助?哪些是违规求助? 9575232
关于积分的说明 21840305
捐赠科研通 7784667
什么是DOI,文献DOI怎么找? 3434891
关于科研通互助平台的介绍 2559294
邀请新用户注册赠送积分活动 2481741